Primadofilus® Junior

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.004205.09.16
Date of registration and renewal:22.09.2016
Dosage form: & nbspCapsule of 175 mg.
Classification "Composition" & nbsp Supplements - probiotics and prebiotics
Classification "Clinical" & nbsp Supplements promoting normalization and maintenance of normal intestinal microflora
Composition: & nbspBiomass lyophilized lactic acid bacteria Lactobacillus rhamnosus, biomass lyophilized lactic bacteria Lactobacillus acidophilus, biomass lyophilized Bifidobacterium Bifidobacterium infantis, biomass lyophilized Bifidobacterium Bifidobacterium longum, biomass lyophilized Bifidobacterium Bifidobacterium breve, ascorbic acid, maltodextrin, E470, gelatine, enteric coating (cellulose, sodium alginate, medium triglycerides, oleic and stearic acids).
Scope: & nbspDFor sale to the population as a biologically active food additive for children 6-12 years - a source of probiotic microorganisms (bifidobacteria and lactobacilli).
Suggested Usage: & nbspChildren 6-12 years - 1 capsule per day with meals. Duration of admission is 2-4 weeks. Reception can be repeated 3-4 times a year.
Contraindications:ANDIndividual intolerance of components.
Special instructions:Before use, consult a pediatrician.
Shelf life:24 months in unopened original packaging.
Storage conditions:Store in refrigerator, at temperature not higher than + 6 ° С.
Research protocols:In exchange for the certificate of state registration No.RU.77.99.88.003.Е.008179.08.15 dated August 3, 2015, expert opinions of the FGBICU "NII Nutrition" №72 / Э-992 / б-15 of 18.06.2015, FGBUN " FIC Nutrition and Biotechnology "No. 529 / E-598 / b-16 of July 14, 2016.
Recipient:Schwabe North America, Inc.Schwabe North America, Inc. USA
Information update date: & nbsp09.10.2016
Instructions
Up